Current Knowledge of Trichosporon spp. and Trichosporonosis
Reads0
Chats0
TLDR
Treating patients with trichosporonosis remains a challenge because of limited data on the in vitro and in vivo activities of antifungal drugs against clinically relevant species of the genus, but the use of antIfungal regimens containing triazoles appears to be the best therapeutic approach.Abstract:
SUMMARY Trichosporon spp. are basidiomycetous yeast-like fungi found widely in nature. Clinical isolates are generally related to superficial infections. However, this fungus has been recognized as an opportunistic agent of invasive infections, mostly in cancer patients and those exposed to invasive medical procedures. It is possible that the ability of Trichosporon strains to form biofilms on implanted devices, the presence of glucuronoxylomannan in their cell walls, and the ability to produce proteases and lipases are all factors likely related to the virulence of this genus and therefore may account for the progress of invasive trichosporonosis. Disseminated trichosporonosis has been increasingly reported worldwide and represents a challenge for both diagnosis and species identification. Phenotypic identification methods are useful for Trichosporon sp. screening, but only molecular methods, such as IGS region sequencing, allow the complete identification of Trichosporon isolates at the species level. Methods for the diagnosis of invasive trichosporonosis include PCR-based methods, Luminex xMAP technology, and, more recently, proteomics. Treating patients with trichosporonosis remains a challenge because of limited data on the in vitro and in vivo activities of antifungal drugs against clinically relevant species of the genus. Despite the mentioned limitations, the use of antifungal regimens containing triazoles appears to be the best therapeutic approach.read more
Citations
More filters
Journal ArticleDOI
Atlas of Clinical Fungi
TL;DR: The atlas compiled by these editors is a commendable effort and welcome addition to the mycology textbook sector.
Journal ArticleDOI
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
Maiken Cavling Arendrup,Teun Boekhout,Teun Boekhout,Teun Boekhout,Murat Akova,Jacques F. Meis,Oliver A. Cornely,O. Lortholary,O. Lortholary +8 more
TL;DR: Recommendations about the microbiological investigation and detection of invasive infection were made and current knowledge on the most appropriate antifungal and supportive treatment was reviewed.
Journal ArticleDOI
Towards an integrated phylogenetic classification of the Tremellomycetes
Xin-Zhan Liu,Qi-Ming Wang,Markus Göker,Marizeth Groenewald,Aleksey V. Kachalkin,H. T. Lumbsch,Ana M. Millanes,Mats Wedin,Andrey Yurkov,Teun Boekhout,Feng-Yan Bai +10 more
TL;DR: Based on the results inferred from molecular data and morphological and physiochemical features, an updated classification for the Tremellomycetes is proposed and five orders, 17 families and 54 genera are accepted, including seven new families and 18 new genera.
Journal ArticleDOI
A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens
Saika Tariq,Saira Wani,Waseem Rasool,Khushboo Shafi,Mohammad Auyoub Bhat,Anil Prabhakar,Aabid H. Shalla,Manzoor A. Rather +7 more
TL;DR: The current review article discusses in detail the various aspects of antimicrobial activity of essential oils in a comprehensive manner.
Book ChapterDOI
Candida, Cryptococcus, and other yeasts of medical importance.
TL;DR: The chapter on Candida, Cryptococcus, and other yeasts of medical importance outlines the taxonomy, epidemiology, and clinical significance of species from as many as 12 yeast genera and contains five tables containing key identification characteristics of yeasts.
References
More filters
Journal ArticleDOI
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben E. De Pauw,Thomas J. Walsh,J. Peter Donnelly,David A. Stevens,John E. Edwards,Thierry Calandra,Peter G. Pappas,Johan Maertens,Olivier Lortholary,Carol A. Kauffman,David W. Denning,Thomas F. Patterson,Georg Maschmeyer,Jacques Bille,William E. Dismukes,Raoul Herbrecht,William W. Hope,Christopher C. Kibbler,Bart Jan Kullberg,Kieren A. Marr,Patricia Muñoz,Frank C. Odds,John R. Perfect,Angela Restrepo,Markus Ruhnke,Brahm H. Segal,Jack D. Sobel,Tania C. Sorrell,Claudio Viscoli,John R. Wingard,Theoklis E. Zaoutis,John E. Bennett +31 more
TL;DR: These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.
Book
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
John H. Rex,Clinical +1 more
TL;DR: A method for testing the susceptibility of antifungal agents to yeast that cause invasive fungal infections, including Candida spp.
Journal ArticleDOI
Atlas of Clinical Fungi
TL;DR: The atlas compiled by these editors is a commendable effort and welcome addition to the mycology textbook sector.
Journal ArticleDOI
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
Livio Pagano,Morena Caira,Anna Candoni,Massimo Offidani,Luana Fianchi,Bruno Martino,Domenico Pastore,Marco Picardi,Alessandro Bonini,Anna Chierichini,Rosa Fanci,Cecilia Caramatti,Rosangela Invernizzi,Daniele Mattei,Maria Enza Mitra,Lorella Melillo,Franco Aversa,Maria Teresa Van Lint,Paolo Falcucci,Caterina Giovanna Valentini,Corrado Girmenia,Annamaria Nosari +21 more
TL;DR: Patients with hematologic malignancies are currently at higher risk of IFI caused by molds than by yeasts, and the incidence of I FI is highest among patients with acute myeloid leukemia.